Photo via Toronto Star

York U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistance

Read the original at Toronto Star ↗
Cite

York U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistance. (2026, September 24). Toronto Star. https://www.thestar.com/globenewswire/york-u-receives-nearly-10-million-from-wellcome-to-continue-the-fight-against-antimicrobial-resistance/article_4a4b8591-bd14-54a4-a39d-4ee66395947a.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-24 · by GlobeNewswire, Inc.

Quick Summary

York University’s Global Strategy Lab received nearly $10 million from Wellcome to support its AMR Policy Accelerator initiative aimed at combating antimicrobial resistance. The four-year strategic plan was unveiled on September 24, 2026, by GSL Director Mathieu JP Poirier and Managing Director Geneviève Boily-Larouche in Toronto. This funding renewal reflects the importance of ongoing efforts to address AMR, which is considered a significant global health issue despite recent advances in scientific research and policy development.
Written by AI on 2026-09-24, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

York University's Global Strategy Lab (GSL) in Toronto, Ontario, received $9.6 million (£5 million) from the global health charity Wellcome to continue its fight against antimicrobial resistance (AMR). The funding supports a four-year strategic plan for the AMR Policy Accelerator, launched by GSL Director Mathieu JP Poirier and Managing Director Geneviève Boily-Larouche. Poirier emphasized that despite the ongoing threat of AMR since 2022, recent global efforts indicate a potential turning point in addressing this "silent pandemic." The initiative aims to leverage new global scientific panels and action plans to make significant progress against AMR.

Written for “Antimicrobial Resistance Funding” on 2026-10-31, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Antimicrobial Resistance Funding
Science · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
5
sentences that state something as happening or true
Uncertain
0%
0 of 5 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Science
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-24 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 10621 article(s) · 27 correction(s) detected
Running correction rate · 27 correction(s)
2026-10-26
Correction
2026-10-24
Correction
2026-10-07
Correction
2026-09-24
Correction

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

Accelerator GSL Ontario Toronto Wellcome

Subjects

Accelerator ORG · 2× GSL ORG · 2× Wellcome ORG · 2× GLOBE NEWSWIRE ORG · 1× Global Strategy Lab ORG · 1× Mathieu JP Poirier PERSON · 1× Ontario GPE · 1× Toronto GPE · 1× York University ORG · 1× the AMR Policy Accelerator ORG · 1×

Narrative

“The threat of antimicrobial resistance is no less pressing today than when we launched the Accelerator in 2022, but we are determined to ensure that the recent adoption of a global scientific panel and action plan for AMR will mark a turning point in the global fight against this silent pandemic
framing: assertive · carried by 1 article(s) · first seen 2026-09-24
🔮 “The threat of antimicrobial resistance is no less pressing today than when we launched the Accelerator in 2022, but we are determined to ensure that the recent adoption of a global scientific panel and action plan for AMR will mark a turning point in the global fight against this silent pandemic

Claims (5 extracted, 0 hedged)

In a global health environment where funding is increasingly tight, York University based Global Strategy Lab (GSL) is launching a four-year strategic plan for its initiative, the AMR Policy Accelerator to drive progress against antimicrobial resistance (AMR). asserted
Lab → base → resistance
Unveiled today by GSL Director Mathieu JP Poirier and Accelerator Managing Director, Geneviève Boily-Larouche, the plan is supported by $9.6 million (£5 million) from Wellcome – a leading global health philanthropy. asserted
plan → unveil → Wellcome
“The threat of antimicrobial resistance is no less pressing today than when we launched the Accelerator in 2022, but we are determined to ensure that the recent adoption of a global scientific panel and action plan for AMR will mark a turning point in the global fight against this silent pandemic asserted
adoption → launch → pandemic
,” says Poirier, also an Associate Professor in the Faculty of Health at York. asserted
Poirier → say → York
“We are proud that Wellcome has been with us since day one, and this renewal of funding signals the impact of our work and the significance of our strategic plan.” asserted
renewal → signal → plan
💬Give feedback
🕘History 🎫Support